These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 15041923)

  • 21. [Reconstruction of hepatitis D virus ribozymes and their ability to trans-cleave hepatitis C virus RNA].
    Yu Y; Mao Q; Li Q; Wang Y; Min F
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):157-9. PubMed ID: 11412391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HDV ribozyme activity in monovalent cations.
    Perrotta AT; Been MD
    Biochemistry; 2006 Sep; 45(38):11357-65. PubMed ID: 16981696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tri-infection: successful treatment of a patient infected with HIV and hepatitis B and C viruses--a case report.
    Johanson F
    AIDS Read; 2004 Jul; 14(7):389-94. PubMed ID: 15282868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient inhibition of hepatitis B virus replication by hammerhead ribozymes delivered by hepatitis delta virus.
    Li X; Kuang E; Dai W; Zhou B; Yang F
    Virus Res; 2005 Dec; 114(1-2):126-32. PubMed ID: 16054262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hammerhead ribozymes: biochemical and chemical considerations.
    Goodchild J
    Curr Opin Mol Ther; 2000 Jun; 2(3):272-81. PubMed ID: 11249621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucosidase inhibitors as antiviral agents for hepatitis B and C.
    Durantel D; Alotte C; Zoulim F
    Curr Opin Investig Drugs; 2007 Feb; 8(2):125-9. PubMed ID: 17328228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delta virus as a vector for the delivery of biologically-active RNAs: possibly a ribozyme specific for chronic hepatitis B virus infection.
    Hsieh SY; Taylor J
    Adv Exp Med Biol; 1992; 312():125-8. PubMed ID: 1514438
    [No Abstract]   [Full Text] [Related]  

  • 28. A conformational switch controls hepatitis delta virus ribozyme catalysis.
    Ke A; Zhou K; Ding F; Cate JH; Doudna JA
    Nature; 2004 May; 429(6988):201-5. PubMed ID: 15141216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, targeting, and initial screening of sTRSV-derived hairpin ribozymes for optimum helix 1 length and catalytic efficiency in vitro.
    Richardson MW; Hostalek L; Dobson M; Hu J; Shippy R; Siwkowski A; Marmur JD; Khalili K; Klotman PE; Hampel A; Rappaport J
    Methods Mol Biol; 2004; 252():339-58. PubMed ID: 15017062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biologically important reactions catalyzed by RNA molecules.
    Ikeda Y; Taira K
    Chem Rec; 2002; 2(5):307-18. PubMed ID: 12369055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of metal ions in ribozymes.
    Pyle AM
    Met Ions Biol Syst; 1996; 32():479-520. PubMed ID: 8640529
    [No Abstract]   [Full Text] [Related]  

  • 32. Catalytic strategies of self-cleaving ribozymes.
    Cochrane JC; Strobel SA
    Acc Chem Res; 2008 Aug; 41(8):1027-35. PubMed ID: 18652494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selection of the most potent specific on/off adaptor-hepatitis delta virus ribozymes for use in gene targeting.
    Lévesque MV; Rouleau SG; Perreault JP
    Nucleic Acid Ther; 2011 Aug; 21(4):241-52. PubMed ID: 21793786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and validation of therapeutic hammerhead ribozymes for autosomal dominant diseases.
    Fritz JJ; Gorbatyuk M; Lewin AS; Hauswirth WW
    Methods Mol Biol; 2004; 252():221-36. PubMed ID: 15017052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical gene therapy research utilizing ribozymes: application to the treatment of HIV/AIDS.
    Ngok FK; Mitsuyasu RT; Macpherson JL; Boyd MP; Symonds GP; Amado RG
    Methods Mol Biol; 2004; 252():581-98. PubMed ID: 15017082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ribonucleic general acid.
    Strobel SA
    Nat Chem Biol; 2005 Jun; 1(1):5-6. PubMed ID: 16407982
    [No Abstract]   [Full Text] [Related]  

  • 37. Linkage between proton binding and folding in RNA: implications for RNA catalysis.
    Bevilacqua PC; Brown TS; Chadalavada D; Lecomte J; Moody E; Nakano SI
    Biochem Soc Trans; 2005 Jun; 33(Pt 3):466-70. PubMed ID: 15916542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of an extruded nucleotide on cleavage activity and dynamic catalytic core conformation of the hepatitis delta virus ribozyme.
    Sefcikova J; Krasovska MV; Spacková N; Sponer J; Walter NG
    Biopolymers; 2007 Apr 5-15; 85(5-6):392-406. PubMed ID: 17253610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C and B viruses: the new opportunists in HIV infection.
    Chung RT
    Top HIV Med; 2006; 14(2):78-83. PubMed ID: 16835462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hammerhead ribozymes with cleavage site specificity for NUH and NCH display significant anti-hepatitis C viral effect in vitro and in recombinant HepG2 and CCL13 cells.
    Gonzalez-Carmona MA; Schüssler S; Serwe M; Alt M; Ludwig J; Sproat BS; Steigerwald R; Hoffmann P; Quasdorff M; Schildgen O; Caselmann WH
    J Hepatol; 2006 Jun; 44(6):1017-25. PubMed ID: 16469406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.